Anti-ribosomal P antibodies are associated with elevated circulating IFNα and IL-10 levels in systemic lupus erythematosus patients
- 8 August 2014
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 23 (14) , 1477-1485
Abstract
The objective of this paper is to analyze the relationship of anti-protein ribosomal P (RibP) antibodies with circulating levels of IFNα, TNFα, IFNγ, IL-17 and IL-10 in SLE. Disease activity and other systemic lupus erythematosus (SLE) features were also analyzed. Anti-RibP and other SLE-related antinuclear antibodies (ANA) were determined by fluoro-enzyme immunoassay in the sera of 107 SLE patients. Circulating cytokines were quantified by flow cytometry (IFNα, IL-10 and IL-17) or ELISA (TNFα and IFNγ). Anti-RibP-positive patients (14.9%) displayed significantly higher serum levels of IFNα (p = 0.023) and IL-10 (p = 0.016) than their negative counterparts. This cytokine upregulation was independent of the presence of other ANA even though, in our patient cohort, anti-dsDNA was found to be associated with anti-RibP (OR, CI 95%: 6.03, 1.32–27.93, p = 0.021) and to correlate with IL-10 levels (r = 0.204, p = 0.036). In fact, patients positive for anti-RibP but negative for anti-dsDNA exhibited the highest amounts of both IL-10 and IFN-α that were not related to disease activity since these patients showed lower SLEDAI than patients also positive for anti-dsDNA (p = 0.018). Anti-RibP positivity was also associated with early diagnosis, hypocomplementemia and leukopenia. Presence of anti-RibP was found to be related to increased serum IFNα and IL-10 levels independently of both antibody status and disease activity.Keywords
This publication has 53 references indexed in Scilit:
- Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2013
- Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profileBMC Medicine, 2013
- Sifalimumab, a Human Anti–Interferon‐α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose‐Escalation StudyArthritis & Rheumatism, 2013
- Prevalence and clinical significance of anti-ribosomal P antibody in childhood-onset systemic lupus erythematosusLupus, 2012
- Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosusArthritis Research & Therapy, 2011
- Anti‐ribosomal phosphoprotein autoantibody triggers interleukin‐10 overproduction via phosphatidylinositol 3‐kinase‐dependent signalling pathways in lipopolysaccharide‐activated macrophagesImmunology, 2009
- Regulatory B cells as inhibitors of immune responses and inflammationImmunological Reviews, 2008
- Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosisJournal of Experimental Medicine, 2007
- Systemic Lupus Erythematosus in Asturias, SpainMedicine, 2006
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992